| Association of Women for the Advancement of Research and Education | Today is | |
|
|
|
| You are here: Home > Managing Menopause > HRT > Premarin > References | Tell a Friend about Us |
|
|
References(for Ivy Greenwell opinion on Premarin) Bhavnani BR. Pharmacokinets and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med 1998; 217: 6-16. Brinton RD et al. Equilin, a principal component of Premarin, increases the growth of cortical neurons via an NMDA receptor-independent mechanism. Exp Neurol 1997; 147:211-220. McManus J et al. The effects of various estrogens and progestogens on the susceptibilitiy of lower-density lipoprotein to oxidation in vitro. Maturitas 1996; 25: 125-31. Subbiah MTR et al. Antioxidant potencies of specific estrogens on lipid peroxides. J Clin Endocrinol Metab 1993; 77: 1095-97. Tang M et al. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism Clin Exp 1996; 45: 411-15. Wilcox JG. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. Fertil Steril 1997; 67: 57-62. Zumoff B. Alcohol, estrogens, and breast cancer. J Clin Endocrinol Metab 1997; 82: 1656-58. (Research assistant for this article: Pamela Macon)
Click for "Premarin: Facts & Opinions"
|
|
|||
|
|
|||||
Copyright © 1997-2008 ProjectAWARE. All rights reserved. Questions or comments about this site? Contact the Website Editor, <aware.editor@project-aware.org>
|
|||||